WOMEN who take aspirin could reduce their risk of one of Australia’s deadliest cancers by up to 30 per cent, research has found.
A 12-year study of nearly 60,000 women aged 50-79 found the longer a woman took the common painkiller, the lower her risk of melanoma.
The findings suggest the anti-inflammatory effects of aspirin may help protect against the potentially deadly skin cancer, but experts warn existing sun safe practices including the use of sunscreen was the best way to prevent skin cancer.
The researchers concluded that aspirin, a nonsteroidal anti-inflammatory drug, “may have a chemoprotective effect against the development of melanoma”.
On average, the reduction in risk for all postmenopausal women taking aspirin was 21 per cent, while women who had taken the drug for five years or more reduced their risk by 30 per cent…Read more